The Role of Innovative Medicines and Therapies in the Fight against Cancer11:30am-1:30pm | Chateau Laurier - 1 Rideau Street, Ottawa
Cancer is more common than most people realize, over 40 % of Canadians will develop cancer in their lifetime. Many Canadians don’t learn they have cancer until it is late-stage, and the vast majority of Canadians are not even aware of specific types of cancer, such as myeloma. Sadly, 1 in 4 Canadians will die from cancer. However, amidst these grim numbers, there is tremendous hope and promise as innovations in cancer drugs and therapies are significantly improving patient-care and re-defining the parameters of life expectancy for Canadians with cancer.
Please join the Economic Club of Canada for a topical and timely armchair discussion aimed at addressing and unlocking the value of innovative medicines, the evolution of cancer treatments and how we can further accelerate this scientific progress.
Special introductory remarks will be made by "Stuntman" Stu.
***Part of the proceeds of this event will be donated to Myeloma Canada, The Canadian Cancer Society and The Ottawa Regional Cancer Foundation***
-Lunch will be served -
Individual seat: $89 +HST
Table (seats 10): $800 +HST
Individual seat: $110 +HST
Table (seats 10): $990 +HST
Event Sponsored by:
Aldo Del Col
Co-Founder and Chairman
Since being diagnosed with multiple myeloma in 2002, Mr Del Col has directed his attention to creating an effective national platform to address the needs of the Canadian myeloma community. In 2004 he founded the Myeloma Montreal Support Network, and in 2005 he co-founded Myeloma Canada. Mr Del Col has focused his efforts on establishing the organization as the voice of the Canadian myeloma community, first as President of the Board of Directors, then as Executive Director from 2010 to 2013, and now as Chairman of the Board. More recently he co-founded the Myeloma Canada Research Network (MCRN), a sister organization to Myeloma Canada, to accelerate the advancement of Canadian myeloma research. Drawing upon his scientific and pharmaceutical background, he works closely with Canada’s leading myeloma researchers, investigators, clinicians, and pharmaceutical companies to drive research focused on optimizing patient outcomes.
Mr Del Col holds a Bachelor of Science in Pharmacy degree from the University of Toronto and a Master in Business Administration from York University. Throughout his extensive career, Mr Del Col has gained knowledge and experience not only as a Community Pharmacist, but also as a Financial Analyst for a multinational pharmaceutical company and National Director of Sales and Marketing for a global health and beauty consumer products corporation.
In addition to his ongoing responsibilities with Myeloma Canada and the Myeloma Canada Research Network, Mr Del Col works part time in a community pharmacy, and serves as the hematology patient representative for the Canadian Cancer Trials Group (CCTG) and as a reviewer for their Clinical Trials Committee. He is also a member of the Global Myeloma Action Network, serves on the Board of Directors of the International Myeloma Foundation, and participates in both national and international advisory boards.
Vice President, Sales & Marketing
Bruce Williamson is the Vice President, Sales and Marketing at Janssen Canada and a member of the company’s Leadership Team. He oversees all aspects of the go-to-market approach and strategy for medicines within Oncology, Psychiatry and Cardiovascular & Metabolics. In addition to his commercial responsibilities, Bruce leads the Janssen Training & Development function, New Business Development and Trade/Supply Chain Operations. With more than 20 years of experience in the healthcare industry, Bruce has extensive knowledge of the pharmaceutical industry, including all aspects of life cycle management, product development and strategic planning.
Darrell White, MD, MSc, FRCPC, FACP
Senior Associate Dean, Faculty of Medicine, Professor, Department of Medicine (Hematology)
QEII Health Sciences Ctr and Dalhousie University
Darrell White is a Professor of Medicine and Senior Associate Dean, Faculty of Medicine, Dalhousie University and a hematologist at the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. He is a graduate of Dalhousie Medical School, trained in Internal Medicine at the University of Western Ontario and Hematology at Dalhousie. He completed a fellowship at the Myeloma and Transplantation Research Center at the University of Arkansas. He has completed graduate studies in Community Health and Epidemiology at Dalhousie.
Since 1998 he has been a member of the Division of Hematology, Department of Medicine at the Queen Elizabeth II Health Sciences Center in Halifax. His research interest and clinical practice focus on transplant and non-transplant treatment of multiple myeloma. He is a member of the Myeloma Sub-Committee of the Canadian Trials Group and is Chair of the Board of the Myeloma Canada Research Network (MCRN). His administrative experience includes being past program director for adult hematology and core internal medicine. He is an examiner for the Royal College of Physicians and Surgeons of Canada for Hematology and Internal Medicine and is Past-Chair of the Royal College Specialty Committee for Hematology.
Linda Eagen, MBA
Founder, Cancer Coaching
President & CEO, Ottawa Regional Cancer Foundation
Linda Eagen is a dynamic, results oriented community leader who has a strong track record of performance in the not-for-profit sector. Linda began her career as a student of psychology and emergency medical care. Her passion for helping others then led her to the fundraising profession. Over 25 years, she has raised more than $250 million for social, arts, health and educational organizations. In 2002 she obtained an MBA from the University of Ottawa.
For the last twelve years, Linda has been the President and CEO of the Ottawa Regional Cancer Foundation. She and her team have raised $50 million for cancer care and research in Eastern Ontario. Linda is the Founder of Cancer Coaching, This innovative person-centered community service complements the work of medical professionals helping people take an active part in their health and wellness.
In 2011, the Cancer Foundation opened the doors to Canada’s first cancer Survivorship Centre built adjacent to the Cancer Survivors Park also a Foundation initiative.
Linda has been recognized for outstanding leadership and community service receiving prestigious awards from the University of Ottawa, the Chamber of Commerce, le Regroupement des Gens d’Affaires, the Change Foundation and the Association of Fundraising Professionals.
Innovative Medicines Canada
Pamela Fralick is an experienced leader who has been fostering positive change in Canada’s health sector for decades. Throughout her career, Ms. Fralick has distinguished herself in a variety of senior roles. A convener and innovator, Ms. Fralick is one of Canada’s leading, compassionate voices in the health sector. As the President of Innovative Medicines Canada, Ms. Fralick leads the industry association for Canada’s innovative pharmaceutical companies, working with its members and communities to ensure Canadians have access to the medicines they need, when they need them.
Prior to joining Innovative Medicines Canada, Ms. Fralick was President and CEO of the Canadian Cancer Society, Canada’s largest health charity, where she oversaw a three-year process of intense transformation, resulting in historic changes to the operational and governance structures of the organization.
Ms. Fralick previously served as president and CEO of the Canadian Healthcare Association (CHA) and as CEO of the Canadian Physiotherapy Association. At both Associations, Ms. Fralick led organizational initiatives designed to enhance sustainability and improve outcomes for the associations, their members and stakeholders. Ms. Fralick has also held senior positions with the Canadian Centre on Substance Abuse and Health Canada’s Alcohol and Other Drugs Unit.
True to her commitment to the health and well-being of Canadians, Ms. Fralick has served on numerous prestigious boards and collaboratives across Canada. She was Chair of the Health Action Lobby (HEAL) and Co-chair the Canadian Coalition for Public Health in the 21st Century (CCPH21). She has been active in many organizations as a senior volunteer, including the Centre for Addiction and Mental Health, the University of Ottawa Institute of Mental Health Research, Triathlon Canada and the International Triathlon Union. She is currently on the board of Outward Bound Canada (Chair) and the Canada Dance Festival (Past Chair).
Ms. Fralick has a BA in French and psychology and an MA in developmental psychology from Carleton University, as well as a Master of Public Administration (MPA) from Queen’s University. She also holds an ICD.D designation. She is trilingual – in English, French and German – and is an accomplished artist and athlete.
Stu Schwartz is a 20 year radio and television veteran in Ottawa, where “Stuntman Stu” became a household name.
In addition to his morning show on MAJIC 100, Stu is the public address announcer for the Ottawa Senators, works with many charities and is a master auctioneer at fund raising events.
A victim of bullying as a child, he created the “NoMoreBullies” campaign where he visits local schools to speak and educate children about the horrible effects of bullying.
Stu is a recipient of a United Way community builder award, Canadian Association of Broadcasters Gold Ribbon award, was named Algonquin College’s top alumni in 2003, and is a recipient of Her Majesty Queen Elizabeth II’s Diamond Jubilee Medal.
Stu has beaten Leukemia, and had a successful bone marrow transplant in the spring of 2016. Always wanting to give back, he launched the #StuStrong campaign which has raised over three hundred thousand dollars for Leukemia and Stem Cell research at the Ottawa Hospital.
In his spare time Stu is an amateur chef, living in Ottawa with his wife Connie and 2 young children, Matteo and Isabella.
To purchase tickets online please click here to sign in, or create a free account.